NewCo to get DSM Biologics and Australian plant says Royal DSM
Royal DSM has confirmed that its biologics manufacturing operations and new Australian facility will be part of the business merged with Patheon in its agreement with JLL.
Archives for January 21, 2014
Pall CEO: ATMI deal doesn't rule out other acquisitions
Buying ATMI will help Pall fill gaps in its up and downstream biomanufacturing tech offerings but the deal does not rule out other acquisitions says CEO, Larry Kingsley
Biocon defends price of biosimilars as it launches Herceptin copycat
Biocon has defended criticism of the high price of its Trastuzumab biosimilar which will become the world's first copycat version of Roche’s Herceptin when launched next month.
Wuxi predicts growth for biologics manufacturing in 2014
WuXi PharmaTech has predicted that demand for its biopharmaceutical manufacturing services will increase this year just days after upping its guidance for fiscal 2013.